However, more recent work has suggested that IFITM3 may enhance SARS-CoV-2 fusion at the plasma membrane, with clear distinctions drawn between enhancement of viral infection at the plasma membrane and amphipathicity-based mechanisms used for endosomal SARS-CoV-2 entry restriction [51]. The gene discussed is IFITM3; the disease is viral infectious disease.